Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China
1. Moderna shares surged over 5% amid China coronavirus concerns. This triggered immediate investor optimism. 2. Pfizer and Novavax also gained despite a broadly weak S&P 500 session. The move highlighted vaccine sector strength. 3. Reports on bat coronavirus potential drove vaccine makers' rally. Investor sentiment focused on near-term opportunities. 4. FDA expert downplayed coronavirus threat as routine. This eased long-term concerns for vaccine stocks.